Reply: We would like to thank Dr Nurkin and colleagues for their interest in our recently published article ‘‘Insurance Status, Not Race is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer.’’ We agree with their conclusions regarding the importance of understanding disparities in accessing minimally invasive surgical techniques for rectal cancer, as studies have demonstrated the short-term superiority of minimally invasive rectal surgery compared with the open approach. In their letter, the authors highlighted their previous article which focused on identifying factors associated with utilization of minimally invasive rectal resection for cancer, inclusive of insurance status. In contrast, our article specifically explored the overlapping association between race and insurance status in use of minimally invasive rectal surgery for cancer. Understanding this relationship is important, given the historic effect of race on cancer treatment in the United States and its overlapping association with insurance coverage. The current shift in the healthcare payer system warrants improved understanding on the effect of insurance status, because it generally relates to minimally invasive surgery, with our publication specifically addressing rectal cancer. The authors raised a question about whether there is a difference in disparate access to robotic compared with laparoscopic techniques for rectal cancer resection. Our study hypothesis did not focus on examining the differences between laparoscopic and robotic surgery. Although this question is important, recent manuscripts including patients from the American College of Surgeons National Cancer Data Base suggest the equivalency of short-term outcomes between laparoscopic and robotic approaches, but concerns remain for increased operative times and potential increased costs with the robotic technique for colorectal resections. Nevertheless, as suggested by the authors, it is fair to assume that the majority of patients included in our study had laparoscopic surgery, given that it is the most common form of minimally invasive rectal technique practiced in the country. In the studies by Gabriel et al and Sun et al, 2.6% and 8.7%, respectively, underwent robotic rectal surgery. These percentages highlight that whereas the popularity of robotic surgery is increasing, the adoption of robotic rectal surgery remains in its infancy. Therefore, factors associated with use of robotic rectal surgery may not be consistent across institutions, as many surgeons are at the beginning of the learning curve and may use different criteria to offer the procedure, limiting the generalizability. More recent and consistent data may be needed to accurately inform the readership regarding national practice patterns of the association between robotic rectal surgery, race, and insurance. Our study demonstrates that insurance status is an important determinant in utilization of minimally invasive approaches for rectal cancer resection in the United States. Patient race, on the contrary, is not associated with open or minimally invasive approach. These findings have important implications with regard to providing equitable oncologic care for patients with rectal cancer and the role of race in the delivery of surgical treatment in the United States. These findings may suggest that improvements have been made in mitigating some of the racial disparities in the surgical management of rectal cancer. Hospitals may need to expand utilization of minimally invasive rectal surgery, especially to patients with disadvantageous insurance coverage, because minimally invasive rectal techniques have been proven to be cost-effective and associated with improved short-term outcomes. This becomes more important with the changing dynamic of our healthcare system and the shift toward value-based reimbursement. As surgeons, we have a duty towards our patients to advocate for equitable access to care, especially in our rapidly changing healthcare environment.
[1]
Jina Kim,et al.
Insurance Status, Not Race, is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer
,
2017,
Annals of surgery.
[2]
R. Pearse,et al.
Features of Postoperative Immune Suppression Are Reversible With Interferon Gamma and Independent of Interleukin-6 Pathways
,
2016,
Annals of surgery.
[3]
I. Dijkstra,et al.
Postoperative Interleukin-6 Level and Early Detection of Complications After Elective Major Abdominal Surgery
,
2016,
Annals of surgery.
[4]
P. Speicher,et al.
Minimally Invasive Versus Open Low Anterior Resection: Equivalent Survival in a National Analysis of 14,033 Patients With Rectal Cancer
,
2016,
Annals of surgery.
[5]
D. Felsher,et al.
MYC regulates the antitumor immune response through CD47 and PD-L1
,
2016,
Science.
[6]
B. Gilmore,et al.
Robotic-Assisted Versus Laparoscopic Colectomy Results in Increased Operative Time Without Improved Perioperative Outcomes
,
2016,
Journal of Gastrointestinal Surgery.
[7]
K. Attwood,et al.
National disparities in minimally invasive surgery for rectal cancer
,
2016,
Surgical Endoscopy.
[8]
G. Chrousos,et al.
Concept of the aortic aneurysm repair-related surgical stress: a review of the literature.
,
2014,
International journal of clinical and experimental medicine.
[9]
M. Cuesta,et al.
Surgical Stress Response and Postoperative Immune Function After Laparoscopy or Open Surgery With Fast Track or Standard Perioperative Care: A Randomized Trial
,
2012,
Annals of surgery.
[10]
M. Harboe,et al.
Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis
,
2009,
Scandinavian journal of immunology.
[11]
M. Ishikawa,et al.
Perioperative immune responses in cancer patients undergoing digestive surgeries
,
2009,
World journal of surgical oncology.
[12]
H. Thaler,et al.
Inflammation and outcome after general thoracic surgery.
,
2007,
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13]
J. Blache,et al.
Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery.
,
2005,
British journal of anaesthesia.
[14]
T. Malek,et al.
Tolerance, not immunity, crucially depends on IL-2
,
2004,
Nature Reviews Immunology.
[15]
J. Norton,et al.
Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress.
,
1987,
The Journal of clinical endocrinology and metabolism.
[16]
B. Champagne,et al.
Comparative effectiveness of laparoscopic versus robot-assisted colorectal resection
,
2013,
Surgical Endoscopy.
[17]
C. Dejong,et al.
Gastrointestinal , Hepatobiliary and Pancreatic Pathology Human Intestinal Ischemia-Reperfusion – Induced Inflammation Characterized Experiences from a New Translational Model
,
2010
.
[18]
P. Kragsbjerg,et al.
Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations.
,
1995,
The European journal of surgery = Acta chirurgica.
[19]
G. Chrousos,et al.
Hormonal responses to surgical stress.
,
1988,
Advances in experimental medicine and biology.